Skip to main content

Neuroblastoma

  • Chapter
  • First Online:
Pediatric Surgery
  • 100 Accesses

Abstract

Neuroblastoma is the commonest malignancy in infancy and the commonest extra-cranial malignant tumour in children. From the time of diagnosis, management is by agreed protocols drawn up by large oncology groups. Using improved diagnostic methods and with greater understanding of tumour biology, tumour staging is more accurate, and different risk groups have been identified. Treatment is then more refined, such that those with less aggressive tumours receive less toxic treatment. The mainstays of treatment include surgery, chemotherapy and radiotherapy. More recently, biological agents have become available with improvement in survival. Overall, about 75% of children with neuroblastoma will survive long term. For those with biologically unfavourable tumours, fewer than 50% will survive, and intensifying current treatment modalities has made little difference. It seems likely that further improvement in outlook awaits the development of new biological agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43(6):1089–1104

    CAS  PubMed  PubMed Central  Google Scholar 

  • Blacklock JWS (1934) Neurogenic tumours of the sympathetic system in children. J Pathol Bacteriol 39:27–48

    Article  Google Scholar 

  • Brodeur GM (2018) Spontaneous regression of neuroblastoma. Cell Tissue Res 372(2):277–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheung N-KV, Dyer MA (2018) Neuroblastoma: developmental biology, cancer genomics, and immunotherapy. Nat Rev Cancer 13(6):397–411

    Article  Google Scholar 

  • Cohn SL, Pearson ADJ, London WB et al (2009) The international neuroblastoma risk group (INRG) classification system: an INRG task force report. J Clin Oncol 27(2):289–297

    Article  PubMed  PubMed Central  Google Scholar 

  • Evans AE, D’Angio GJ, Randolph J (1971) A proposed staging system for children with neuroblastoma. Children’s cancer study Group A. Cancer 27:374–378

    Article  CAS  PubMed  Google Scholar 

  • Farber S (1940) Neuroblastoma. Am J Dis Child 60:749–750

    Google Scholar 

  • Fortner J, Nicastri A, Murphy ML (1968) Neuroblastoma: natural history and results of treating 133 cases. Ann Surg 167:132–142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • James DH, Hustu O, Wrenn EL et al (1965) Combination chemotherapy in childhood neuroblastoma. JAMA 194:123–126

    Article  Google Scholar 

  • Johnsen JI, Dyberg C, Wickström M (2019) Neuroblastoma-a neural crest derived embryonal malignancy. Front Mol Neurosci 29(12):9

    Article  Google Scholar 

  • Kastriti ME, Kameneva P, Kamenev D et al (2019) Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia. Front Mol Neurosci 12:6–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kiely E (2005) A technique for excision of abdominal and pelvic neuroblastomas. Ann Roy Coll Surg Engl 89:342–348

    Article  Google Scholar 

  • Lehman EP (1932) Adrenal neuroblastoma in infancy – 15 year survival. Ann Surg 95:473

    Google Scholar 

  • Monclair T, Brodeur GM, Ambros PF et al (2009) The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol 27(2):298–303

    Article  PubMed  PubMed Central  Google Scholar 

  • Newman EA, Abdessalam S, Aldrink JH et al (2019) Update on neuroblastoma. J Pediatr Surg 54(3):383–389

    Article  PubMed  Google Scholar 

  • Phillips R (1953) Neuroblastoma. Ann R Coll Surg Engl 12:29–47

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ryan AL, Akinkuotu A, Pierro A et al (2020) The role of surgery in high-risk neuroblastoma. J Pediatr Hematol Oncol 42(1):1–7

    Article  PubMed  Google Scholar 

  • Tsubota S, Kadomatsu K (2018). Origin and initiation Mechanisms of neuroblastoma. Cell Tissue Res 372:211–221

    Google Scholar 

  • Virchow R (1864) Die Krankenhaften Geschwulste, vol 11. Hirschwald, Berlin, p 149

    Google Scholar 

  • Wright JH (1910) Neurocytoma or neuroblastoma, a kind of tumour not generally recognised. J Exp Med 12:556–561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kiely, E. (2023). Neuroblastoma. In: Puri, P., Höllwarth, M.E. (eds) Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-81488-5_49

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-81488-5_49

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-81487-8

  • Online ISBN: 978-3-030-81488-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics